Human MSC-Derived Exosomes Reduce Cellular Senescence in Renal Epithelial Cells
Chieh Ming Liao1, Tianjiao Luo2, Juliane von der Ohe2
1Department of Nephrology and Hypertension, Hannover Medical School, 30625 Hannover, Germany.
International Journal of Molecular Sciences
|December 24, 2021
Summary
Mesenchymal stem cell (MSC) exosomes reduce kidney cell senescence and promote proliferation. This suggests MSC exosomes are a promising therapy for age-related kidney disorders and organ rejuvenation.
Area of Science:
- Cellular and Molecular Medicine
- Regenerative Medicine
- Nephrology
Background:
- Cellular senescence in renal tubular cells contributes to chronic kidney diseases and age-related kidney dysfunction.
- Therapies targeting senescence are being investigated as novel treatments for nephropathy.
- Mesenchymal stem cell (MSC)-derived exosomes carry bioactive molecules with regenerative potential, showing promise in treating kidney diseases.
Purpose of the Study:
- To investigate the potential of MSC-derived exosomes in antagonizing senescence in kidney cells.
- To evaluate the therapeutic effects of MSC exosomes on aged murine kidney primary tubular epithelial cells (PTEC).
Main Methods:
- MSC-derived exosomes were isolated and characterized.
- Aged MSC cultures were treated with exosomes to assess proliferation and senescence.
- Murine kidney primary tubular epithelial cells (PTEC) were treated with MSC-derived exosomes to evaluate senescence markers and proliferation.
- Analysis included transcription of senescence markers and senescence-associated secretory phenotype (SASP) factors, DNA damage foci, and cell proliferation.
Main Results:
- Exosomes promoted proliferation and reduced senescence in aged MSC cultures.
- MSC exosome treatment significantly reduced senescence in murine kidney PTEC.
- A decrease in the transcription of senescence markers and SASP factors was observed.
- Reduced DNA damage foci and increased cell proliferation were noted in exosome-treated PTEC.
Conclusions:
- MSC-derived exosomes demonstrate a therapeutic capacity to antagonize renal senescence.
- These findings support the potential of MSC exosomes as regenerative vehicles for senotherapy in kidney diseases.
- MSC exosomes offer a promising avenue for organ rejuvenation strategies in nephropathy.
More Related Videos
09:32Collection of Serum- and Feeder-free Mouse Embryonic Stem Cell-conditioned Medium for a Cell-free Approach
Published on: January 8, 2017
10.4K
13:59A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
Published on: August 12, 2018
8.3K
Related Concept Videos
01:19Mesenchymal Stem Cells
5.1K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.1K
02:15Replicative Cell Senescence
3.8K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
3.8K
01:36Overview of Exosomes
2.9K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.9K
01:19Clinical Applications of Epidermal Stem Cells
2.8K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.8K